1. Home
  2. NAMS vs WWW Comparison

NAMS vs WWW Comparison

Compare NAMS & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • WWW
  • Stock Information
  • Founded
  • NAMS 2019
  • WWW 1883
  • Country
  • NAMS Netherlands
  • WWW United States
  • Employees
  • NAMS N/A
  • WWW N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • WWW Shoe Manufacturing
  • Sector
  • NAMS Health Care
  • WWW Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • WWW Nasdaq
  • Market Cap
  • NAMS 2.7B
  • WWW 2.5B
  • IPO Year
  • NAMS N/A
  • WWW N/A
  • Fundamental
  • Price
  • NAMS $26.73
  • WWW $30.40
  • Analyst Decision
  • NAMS Strong Buy
  • WWW Buy
  • Analyst Count
  • NAMS 10
  • WWW 6
  • Target Price
  • NAMS $41.40
  • WWW $29.67
  • AVG Volume (30 Days)
  • NAMS 984.0K
  • WWW 1.6M
  • Earning Date
  • NAMS 11-05-2025
  • WWW 11-06-2025
  • Dividend Yield
  • NAMS N/A
  • WWW 1.31%
  • EPS Growth
  • NAMS N/A
  • WWW N/A
  • EPS
  • NAMS N/A
  • WWW 1.04
  • Revenue
  • NAMS $64,006,000.00
  • WWW $1,821,400,000.00
  • Revenue This Year
  • NAMS N/A
  • WWW $7.52
  • Revenue Next Year
  • NAMS $1.67
  • WWW $6.57
  • P/E Ratio
  • NAMS N/A
  • WWW $29.40
  • Revenue Growth
  • NAMS 762.15
  • WWW N/A
  • 52 Week Low
  • NAMS $14.06
  • WWW $9.58
  • 52 Week High
  • NAMS $27.35
  • WWW $32.80
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 59.23
  • WWW 57.47
  • Support Level
  • NAMS $23.05
  • WWW $29.37
  • Resistance Level
  • NAMS $27.35
  • WWW $31.25
  • Average True Range (ATR)
  • NAMS 1.52
  • WWW 0.94
  • MACD
  • NAMS -0.11
  • WWW -0.45
  • Stochastic Oscillator
  • NAMS 85.58
  • WWW 30.03

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.

Share on Social Networks: